The Lipid-Rich Plaque Study

CompletedOBSERVATIONAL
Enrollment

1,563

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

April 30, 2018

Study Completion Date

September 30, 2018

Conditions
Coronary Artery DiseaseAtherosclerosis
Interventions
DEVICE

NIRS-IVUS Imaging (TVC Imaging System)

Diagnostic Imaging Catheter

Trial Locations (41)

Unknown

University of California Los Angeles Medical Center, Los Angeles

Washington Hospital Center, Washington D.C.

JFK Medical Center, Atlantis

Delray Medical Center, Delray Beach

Palmetto General Hospital, Hialeah

Florida Hospital Orlando, Orlando

Palm Beach Gardens Medical Center, Palm Beach Gardens

Memorial Hospital West, Pembroke Pines

Emory Midtwon, Atlanta

Emory University, Atlanta

Alexian Brothers Heart and Vascular Institute, Elk Grove Village

St. John's Springfield, Springfield

Community Heart & Vascular, Indianapolis

Methodist, Merrillville

Central Baptist Hospital, Lexington

McLaren Bay Region, Bay City

St. John's, Detroit

McLaren-Macomb, Mount Clemens

Crittenton Hospital, Rochester

University of Minnesota Medical Center, Minneapolis

Columbia University, New York

LIJ Health System, New York

New York Presbyterian Hospital Cornell, New York

Metrohealth, Cleveland

Hillcrest Oklahoma Heart Institute, Tulsa

Medical University of South Carolina, Charleston

University of Texas Medical Branch, Galveston

St. Luke's Episcopal Hospital, Houston

Heart Hospital Plano, Plano

Davis Hospital and Medical Center, Layton

Charleston Area Medical Center, Charleston

San Biovanni Hospital, Rome

Latvian Centre of Cardiology, Riga

Academic Medical Center, Amsterdam

Radboud University Medical Centre, Nijmegen

Erasmus Medical Centre, Rotterdam

Maasstad Ziekenhuis, Rotterdam

SUSCCH, a.s., Banská Bystrica

Golden Jubilee National Hospital, Clydebank

University of Edinburgh, Edinburgh

Royal Brompton Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Medstar Health Research Institute

OTHER

lead

Infraredx

INDUSTRY